Complementary and alternative treatments

Neurology

Volumn 60, Issue 7 SUPPL. 2, 2003, Pages

  Holroyd, Kenneth A ^a   Mauskop, Alexander ^b  

^a OHIO UNIVERSITY   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSAICIN; GINGER EXTRACT; GINKGO BILOBA EXTRACT; GUARANA; HERBACEOUS AGENT; MAGNESIUM; PEPPERMINT OIL; RIBOFLAVIN; TANACETUM PARTHENIUM EXTRACT; UNCLASSIFIED DRUG; VALERIAN;

ACUPUNCTURE; ALTERNATIVE MEDICINE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONFERENCE PAPER; DIARRHEA; DIET SUPPLEMENTATION; DRUG SCREENING; FEEDBACK SYSTEM; HEADACHE; HERBAL MEDICINE; HUMAN; META ANALYSIS; NUTRITION; PRIORITY JOURNAL; RELAXATION TRAINING;

EID: 0037426376     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (31)

1. Astin JA. Why patients use alternative medicine: results of a national study. JAMA 1998;279:1548-1553.
2. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-252.
3. Campbell JK, Penzien DB, Wall EM. Evidence-based guidelines for migraine headache: behavioral and physical treatments. Available at http://www.aan.com. Accessed November 20, 2000.
4. Martin PR. Psychological management of chronic headaches. New York: Guilford Press, 1993.
5. Bernstein DA, Borkovec TD. Progressive relaxation training. A manual for the helping professions. Champaign, IL: Research Press, 1973.
6. Schultz JH, Luthe W. Autogenic training: a psychophysiologic approach in psychotherapy. New York: Grune & Stratton, 1959.
7. Benson H. The relaxation response. Psychophysiologic aspects and clinical applications. New York: Morrow, 1975:87-98. Report 06880.29558.
8. Schwartz MS. Biofeedback. A practitioner's guide, 2nd ed. New York: Guilford Press, 1995.
9. Haddock CK, Rowan AB, Andrasik F, Wilson PG, Talcott GW, Stein RJ. Home-based behavioral treatments for chronic benign headache: a meta-analysis of controlled trials. Cephalalgia 1997;17:113-118.
10. Goslin RE, Gray RN, McCrory DC. Behavioral and physical treatments for migraine headache. Agency for Healthcare Research and Quality Technical Review 2.2, 1999:1-140.
11. Penzien DB, Holroyd KA, Hursey KG, Holm JE, Wittchen HU. Behavioral treatment of recurrent migraine: a meta-analysis of over five-dozen group outcome studies. Paper presented at the Association for Advancement of Behavior Therapy Meeting, Houston, Guilford Press, 1985.
12. Blanchard EB, Andrasik F. Psychological assessment and treatment of headache: recent developments and emerging issues. J Consult Clin Psychol 1982;50:859-879.
13. Holroyd KA, Penzien DB. Pharmacological versus non-pharmacological prophylaxis of recurrent migraine headache: a meta-analytic review of clinical trials. Pain 1990;42:1-13.
14. Hermann C, Kim M, Blanchard EB. Behavioral and prophylactic pharmacological intervention studies of pediatric migraine: an exploratory meta-analysis. Pain 1995;60:239-255.
15. Silberstein SD, Rosenberg J. Multispecialty consensus on diagnosis and treatment of headache. Neurology 2000;54:1553. Abstract.
16. National Institutes of Health. Acupuncture. NIH consensus statement 1997;15:1-34.
17. Dowson DI, Lewith GT, Machin D. The effects of acupuncture versus placebo in the treatment of headache. Pain 1985;21:35-42.
18. Vincent CA. A controlled trial of the treatment of migraine by acupuncture. Clin J Pain 1989;5:305-312.
19. Loh L, Nathan PW, Schott GD, Zilkha KJ. Acupuncture versus medical treatment for migraine and muscle tension headaches. J Neurol Neurosurg Psychiatry 1984;47:333-337.
20. Hesse J, Mogelvang B, Simonsen H. Acupuncture versus metoprolol in migraine prophylaxis: a randomized trial of trigger point inactivation. J Intern Med 1994;235:451-456.
21. Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci 1998;5:24-27.
22. Sarchielli P, Coata G, Firenze C, Morucci P, Abbritti G, Gallai V. Serum and salivary magnesium levels in migraine and tension-type headache. Results in a group of adult patients. Cephalalgia 1992;12:21-27.
23. Soriani S, Arnaldi C, De Carlo L, et al. Serum and red blood cell magnesium levels in juvenile migraine patients. Headache 1995;35:14-16.
24. Facchinetti F, Sances G, Borella P, Genazzani AR, Nappi G. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991;31:298-301.
25. Mauskop A, Altura BT, Cracco RQ, Altura BM. Intravenous magnesium sulphate relieves migraine attacks in patients with low serum ionized magnesium levels: a pilot study. Clin Sci (Colch) 1995;89:633-636.
26. Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia 1996;16:257-263.
27. Wang F, Van Den Eeden S, Ackerson L, Salk S, Reince R. Oral magnesium oxide prophylaxis of frequent childhood migraine. Cephalalgia 2000;20:424. Abstract.
28. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998;50:466-470.
29. Murphy JJ, Heptinstall S, Mitchell JRA. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 1988;2:189-192.
30. Gobel H, Schmidt G, Soyka D. Effect of peppermint and eucalyptus oil preparations on neurophysiological and experimental algesimetric headache parameters. Cephalalgia 1994;14:228-234.
31. Gobel H, Heinze A, Dworschak M. Oleum menthae piperitae significantly reduces the symptoms of tension-type headache and its efficacy does not differ from that of acetaminophen. In: Olesen J, Tfelt-Hansen P, eds. Headache treatment: trial methodology and new drugs. Philadelphia: Lippincott-Raven, 1997:169-174.